Target intelligence / Profile preview

Betaine-homocysteine S-methyltransferase 2 (BHMT2)

Target
BHMT2
Molecular classification
Enzyme, Transferase, Methyltransferase, Zinc metalloenzyme
01

Overview

Betaine-homocysteine S-methyltransferase 2 (BHMT2) is a zinc-dependent metalloenzyme that catalyzes the transfer of a methyl group from S-methylmethionine (SMM, also known as vitamin U, often derived from plant-based foods) to homocysteine, generating methionine[1][2][5]. Unlike its close homolog BHMT, which uses betaine as a methyl donor, BHMT2 is specific for SMM and is unable to utilize betaine as a substrate[1][2]. The enzyme plays a role in methionine biosynthesis as part of the broader one-carbon metabolic pathway, which is essential for methyl group transfer and regulation of homocysteine, a metabolite associated with cardiovascular and other diseases when dysregulated[3][5]. BHMT2’s tissue expression and physiological details are less well characterized than BHMT, but it is known to be present in the liver[5]. Disease associations for BHMT2 are inferred based on its role in homocysteine/methionine metabolism, with possible links to cardiovascular and metabolic diseases; however, unlike BHMT, direct drug targeting, interacting drugs, or use as a clinical biomarker are not established[5].\n\nKey characteristics:\n- BHMT2 is part of the methyltransferase (specifically, S-methylmethionine-homocysteine methyltransferase) family and shares structural elements with the broader Pfam 02574 family of enzymes[1].\n- It displays high specificity for SMM and does not use betaine, with differences in substrate binding sites explaining selectivity compared to BHMT[1].\n- BHMT2 is a zinc metalloenzyme and may oligomerize, with possible regulatory or evolutionary interactions with BHMT[1].\n- Though it can catalyze the methylation of homocysteine using S-adenosylmethionine (AdoMet) in vitro, its primary physiological function appears centered on SMM[1][2].\n- No known drugs directly target BHMT2, and no safety or toxicology concerns are reported in the literature[5].\n- No clinically established biomarkers or mechanisms of action for drugs targeting BHMT2 are known according to current public biomedical resources.

Other names
S-methylmethionine-homocysteine S-methyltransferase BHMT2SMM-hcy methyltransferasebetaine-homocysteine methyltransferase 2BHMT-2
02

Biological functions

Homocysteine metabolismMethionine biosynthesisOne-carbon metabolism
03

Disease associations

Cardiovascular diseaseOther (implicated in disorders via homocysteine/methionine metabolism, though direct involvement less well-characterized than BHMT)

Beyond the preview

Go deeper on Betaine-homocysteine S-methyltransferase 2 (BHMT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Betaine-homocysteine S-methyltransferase 2 (BHMT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call